CROSSBOSS™

Coronary CTO Crossing Catheter

The CROSSBOSS Catheter allows you to treat complex lesions safely, with maximum efficiency and success.
Atraumatic, rounded tip reduces risk of perforation.
Hydrophilic coated, multi-wire coiled shaft provides precise turn-for-turn response.
Fast-Spin torque device allows rapid rotation of the catheter to facilitate crossing.
play icon
View the CROSSBOSS and STINGRAY Re-Entry System procedure animation.
The CROSSBOSS Catheter allows you to treat complex lesions safely, with maximum efficiency and success.
Atraumatic, rounded tip reduces risk of perforation.
Hydrophilic coated, multi-wire coiled shaft provides precise turn-for-turn response.
Fast-Spin torque device allows rapid rotation of the catheter to facilitate crossing.
View the CROSSBOSS and STINGRAY Re-Entry System procedure animation.

Designed to quickly and safely deliver a guidewire via the true lumen or subintimal pathways, CROSSBOSS Catheter gives you total access to coronary chronic total occlusions.

Key Resources

Explore

Specifications

Ordering Information

UPN # Catalog Number Product Name/Description C Code
H749M2000A0 M-2000-A CROSSBOSS Catheter C1725
08714729903352 (GTIN) 39312-0SR STINGRAY LP Device C1725
H749M3004A0 M-3004-A STINGRAY Guidewire 300 cm C1769
H749M3010A0 M-3010-A STINGRAY Extension Wire C1769
H749M3012A0 M-3012-A STINGRAY Guidewire 185 cm C1769

Clinical Information

FAST-CTO Trial

Facilitated Antegrade Steering Technique in Chronic Total Occlusions

The FAST-CTO trial demonstrated the safety and efficacy of the CROSSBOSS and STINGRAY Coronary CTO Crossing and Re-Entry devices to recanalize coronary CTOs in comparison to historical controls.

  • Multi-center, non-randomized US IDE study
  • 147 patients in 16 centers

Safe and Effective

Use of the CROSSBOSS and STINGRAY Crossing and Re-Entry devices result in a high technical success, 77%, without increasing complications.1

Reduced Procedure Time

Procedural success was improved with a 28.1% reduction in mean procedure time (minutes) as well as a reduction in fluoroscopy time.1

Primary Endpoints
Secondary Endpoint

Principal Investigators

Patrick Whitlow MD, William Lombardi MD, Michael Wyman MD, Craig Thompson MD

Cleveland Clinic, PeaceHealth Medical Center/St Joseph Hospital, Torrance Memorial Medical Center, Yale University School of Medicine

 
Master the Complex - For Complete Revascularization
Top